Article Text

Download PDFPDF
Next frontier in management of atrial fibrillation

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Twitter @NicoleLowres

  • Contributors All authors contributed equally to the concepts and assisted with drafting the article.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests NL reports grants from BMS/Pfizer outside the submitted work. KG has received honoraria from Pfizer for professional activities outside the submitted work. BF reports grants, personal fees and non-financial support from BMS/Pfizer; grants, personal fees and non-financial support from Bayer; personal fees and non-financial support from Daiichi Sankyo; non-financial support from Alivecor; and personal fees and non-financial support from Omron outside the submitted work.

  • Patient and public involvement Patients and/or the public were not involved in the design, conduct, reporting or dissemination plans of this research.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles